News & Stories
We bring together unparalleled knowledge and experience in smart, randomized controlled trial design with the use of data and technology to transform both the quality and affordability of clinical trials.
Tackling common disease burden through clinical trial innovation
As part of New Scientist’s 2023 campaign on innovation in clinical research and development, Prof Sir Martin Landray explores the pressing need to transform clinical trials.Read More
The Economist interviews Prof Sir Martin Landray
As clinical trials continue to become too costly and complex, The Economist interviewed Protas’ Chief Executive, Prof Sir Martin Landray,...
Richard Haynes joins Protas Executive as Chief Scientist
Protas is delighted to announce the appointment of Professor Richard Haynes MBE DM FRCP to its Executive team as our...